NanoEcho AB (publ) (STO:NANECH)
Sweden · Delayed Price · Currency is SEK 0.0498
-0.0006 (-1.19%)
At close: Apr 24, 2026
NanoEcho AB Company Description
NanoEcho AB (publ) engages in developing a new diagnostic method to determine the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is headquartered in Lund, Sweden.
NanoEcho AB (publ)
| Country | Sweden |
| Founded | 2013 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 6 |
| CEO | Bjorn Larsson |
Contact Details
Address: Scheelevägen 19 Lund, 223 63 Sweden | |
| Phone | 46 7 09 24 11 21 |
| Website | nanoecho.se |
Stock Details
| Ticker Symbol | NANECH |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Bjorn Larsson | Acting Chief Executive Officer and Director |
| Henrik Ljung | Chief Financial Officer |
| Magnus Santesson | Chief Technology Officer |